BlackRock, Inc. 13D and 13G filings for Dianthus Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-07-28 4:44 pm Purchase | 2026-06-30 | 13G | DIANTHUS THERAPEUTICS INC DNTH | BlackRock Inc. BLK | 3,504,166 6.400% | 870,162 (+33.04%) | Filing |
| 2026-04-27 4:12 pm Purchase | 2026-03-31 | 13G | DIANTHUS THERAPEUTICS INC DNTH | BlackRock Inc. BLK | 2,634,004 5.100% | 1,033,851 (+64.61%) | Filing |
| 2025-04-24 2:17 pm Sale | 2025-03-31 | 13G | DIANTHUS THERAPEUTICS INC DNTH | BlackRock Inc. BLK | 1,600,153 5.000% | -44,666 (-2.72%) | Filing |
| 2024-11-08 5:31 pm Unchanged | 2024-09-30 | 13G | DIANTHUS THERAPEUTICS INC DNTH | BlackRock Inc. BLK | 1,644,819 5.600% | 0 (Unchanged) | Filing |
| 2024-10-24 2:02 pm Purchase | 2024-09-30 | 13G | DIANTHUS THERAPEUTICS INC DNTH | BlackRock Inc. BLK | 1,644,819 5.600% | 1,644,819 (New Position) | Filing |